Tearsheet

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

0

Strong revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 18%

Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 28%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 17%

Attractive yield
Dividend Yield is 2.1%

Low stock price volatility
Vol 12M is 19%

Megatrend and thematic drivers
Megatrends include Aging Population & Chronic Disease, and Sustainable & Green Buildings. Themes include Geriatric Care, and ESG REITs.

Trading close to highs
Dist 52W High is 0.0%, Dist 3Y High is 0.0%

Expensive valuation multiples
P/EBITPrice/EBIT or Price/(Operating Income) ratio is 48x, P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 25x, P/EPrice/Earnings or Price/(Net Income) is 164x

Key risks
VTR key risks include [1] significant labor cost pressures and staffing shortages within its senior housing portfolio, Show more.

0 Strong revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 18%
1 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 28%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 17%
2 Attractive yield
Dividend Yield is 2.1%
3 Low stock price volatility
Vol 12M is 19%
4 Megatrend and thematic drivers
Megatrends include Aging Population & Chronic Disease, and Sustainable & Green Buildings. Themes include Geriatric Care, and ESG REITs.
5 Trading close to highs
Dist 52W High is 0.0%, Dist 3Y High is 0.0%
6 Expensive valuation multiples
P/EBITPrice/EBIT or Price/(Operating Income) ratio is 48x, P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 25x, P/EPrice/Earnings or Price/(Net Income) is 164x
7 Key risks
VTR key risks include [1] significant labor cost pressures and staffing shortages within its senior housing portfolio, Show more.

Valuation, Metrics & Events

Price Chart

Why The Stock Moved

Qualitative Assessment

AI Analysis | Feedback

Ventas (VTR) stock has gained about 15% since 12/31/2025 because of the following key factors:

1. Exceptional Q1 2026 Performance Driven by Senior Housing Operating Portfolio (SHOP).

Ventas reported a 9% year-over-year increase in Normalized Funds From Operations (FFO) per share to $0.94 and a 22% rise in revenue to $1.66 billion for Q1 2026, exceeding analyst estimates. This strong performance was primarily fueled by its Senior Housing Operating Portfolio (SHOP) segment, which achieved a Same-Store Cash Net Operating Income (NOI) growth of over 15% and an average occupancy increase of 310-370 basis points year-over-year.

2. Increased Full-Year Guidance and Strategic Senior Housing Investments.

Following the robust Q1 results, Ventas raised its full-year 2026 guidance for Normalized FFO per share to a range of $3.82-$3.89. The company has also been actively deploying capital, having closed $1.7 billion in senior housing investments year-to-date through April 2026, and increased its full-year investment target for 2026 to $3 billion, focusing on high-growth senior housing opportunities.

Show more
Holding a concentrated position? Know your true downside before the momentum shifts.
Protect Your Wealth →

Stock Movement Drivers

Fundamental Drivers

The 13.9% change in VTR stock from 12/31/2025 to 4/28/2026 was primarily driven by a 11.5% change in the company's P/E Multiple.
(LTM values as of)123120254282026Change
Stock Price ($)76.8987.5713.9%
Change Contribution By: 
Total Revenues ($ Mil)5,5555,8345.0%
Net Income Margin (%)4.3%4.3%0.6%
P/E Multiple147.3164.311.5%
Shares Outstanding (Mil)456472-3.3%
Cumulative Contribution13.9%

LTM = Last Twelve Months as of date shown

Market Drivers

12/31/2025 to 4/28/2026
ReturnCorrelation
VTR13.9% 
Market (SPY)5.2%15.9%
Sector (XLRE)9.6%56.6%

Fundamental Drivers

The 26.7% change in VTR stock from 9/30/2025 to 4/28/2026 was primarily driven by a 19.5% change in the company's Net Income Margin (%).
(LTM values as of)93020254282026Change
Stock Price ($)69.1287.5726.7%
Change Contribution By: 
Total Revenues ($ Mil)5,3025,83410.0%
Net Income Margin (%)3.6%4.3%19.5%
P/E Multiple163.6164.30.4%
Shares Outstanding (Mil)453472-4.0%
Cumulative Contribution26.7%

LTM = Last Twelve Months as of date shown

Market Drivers

9/30/2025 to 4/28/2026
ReturnCorrelation
VTR26.7% 
Market (SPY)8.0%1.3%
Sector (XLRE)6.1%48.2%

Fundamental Drivers

The 30.9% change in VTR stock from 3/31/2025 to 4/28/2026 was primarily driven by a 161.5% change in the company's Net Income Margin (%).
(LTM values as of)33120254282026Change
Stock Price ($)66.9287.5730.9%
Change Contribution By: 
Total Revenues ($ Mil)4,9245,83418.5%
Net Income Margin (%)1.6%4.3%161.5%
P/E Multiple347.2164.3-52.7%
Shares Outstanding (Mil)421472-10.7%
Cumulative Contribution30.9%

LTM = Last Twelve Months as of date shown

Market Drivers

3/31/2025 to 4/28/2026
ReturnCorrelation
VTR30.9% 
Market (SPY)29.3%21.4%
Sector (XLRE)8.6%53.7%

Fundamental Drivers

The 122.6% change in VTR stock from 3/31/2023 to 4/28/2026 was primarily driven by a 85.9% change in the company's P/S Multiple.
(LTM values as of)33120234282026Change
Stock Price ($)39.3487.57122.6%
Change Contribution By: 
Total Revenues ($ Mil)4,1295,83441.3%
P/S Multiple3.87.185.9%
Shares Outstanding (Mil)400472-15.3%
Cumulative Contribution122.6%

LTM = Last Twelve Months as of date shown

Market Drivers

3/31/2023 to 4/28/2026
ReturnCorrelation
VTR122.6% 
Market (SPY)81.5%24.8%
Sector (XLRE)30.2%64.0%

Return vs. Risk

Price Returns Compared

 202120222023202420252026Total [1]
Returns
VTR Return8%-9%15%22%35%10%106%
Peers Return14%-16%13%19%10%5%48%
S&P 500 Return27%-19%24%23%16%5%91%

Monthly Win Rates [3]
VTR Win Rate50%50%58%67%75%75% 
Peers Win Rate55%40%58%67%52%50% 
S&P 500 Win Rate75%42%67%75%67%50% 

Max Drawdowns [4]
VTR Max Drawdown-6%-28%-9%-16%-3%-3% 
Peers Max Drawdown-13%-25%-14%-12%-15%-4% 
S&P 500 Max Drawdown-1%-25%-1%-2%-15%-7% 


[1] Cumulative total returns since the beginning of 2021
[2] Peers: WELL, OHI, HR, ARE, NHI. See VTR Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 4/28/2026 (YTD)

How Low Can It Go

Unique KeyEventVTRS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-43.4%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven76.6%34.1%
2022 Inflation ShockTime to BreakevenTime to Breakeven696 days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-73.1%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven271.5%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven741 days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-34.7%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven53.2%24.7%
2018 CorrectionTime to BreakevenTime to Breakeven479 days120 days
2008 Global Financial Crisis2008 Global Financial Crisis  
2008 Global Financial Crisis% Loss% Loss-64.2%-56.8%
2008 Global Financial Crisis% Gain to Breakeven% Gain to Breakeven179.0%131.3%
2008 Global Financial CrisisTime to BreakevenTime to Breakeven602 days1,480 days

Compare to WELL, OHI, HR, ARE, NHI

In The Past

Ventas's stock fell -43.4% during the 2022 Inflation Shock from a high on 3/29/2022. A -43.4% loss requires a 76.6% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Ventas (VTR)

Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries – healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.

AI Analysis | Feedback

Here are a few brief analogies for Ventas (VTR):

  • Public Storage for healthcare buildings.
  • The American Tower of medical facilities.
  • Blackstone for hospitals and senior living.

AI Analysis | Feedback

  • Healthcare Real Estate Leasing: Ventas provides a diversified portfolio of healthcare properties, including senior housing, medical office buildings, and research centers, for lease to leading healthcare organizations and providers.
  • Healthcare Real Estate Investment & Management: Operating as an REIT, Ventas strategically invests capital to acquire, develop, and manage healthcare real estate assets, aiming to generate consistent cash flows and superior returns for its shareholders.

AI Analysis | Feedback

Ventas (VTR) sells primarily to other companies and institutions, not individuals. As a Real Estate Investment Trust (REIT) focused on healthcare properties, its major customers are the operators and tenants of its owned or managed facilities. Ventas derives its revenue from lease payments or from participation in the operating results of these properties.

Based on Ventas's business model and public disclosures, its major customers and partners include:

  • Atria Senior Living: A significant operating partner for Ventas's Senior Housing Operating (SHOP) portfolio. Atria manages a substantial portion of Ventas's senior living communities. (Private company)
  • Ardent Health Services: A key tenant in Ventas's triple-net lease hospital portfolio. (Private company)
  • PruittHealth: An operator of skilled nursing facilities and a tenant in Ventas's triple-net lease portfolio. (Private company)
  • Various leading healthcare systems, universities, and life science companies: For its Medical Office Building (MOB) and Research & Innovation (R&I) properties, Ventas has a diverse tenant base. While no single public company typically dominates this segment, these tenants include major hospital networks (often non-profit), academic institutions, and biotechnology firms.

AI Analysis | Feedback

null

AI Analysis | Feedback

Here is information about the management team members of Ventas (VTR):

Debra A. Cafaro
Chairman and Chief Executive Officer

Debra A. Cafaro has served as Ventas's Chairman and Chief Executive Officer since 1999. Under her leadership, Ventas's market capitalization grew from $200 million in 1999 to $28 billion by 2019. Before joining Ventas, Cafaro was President of an NYSE-listed apartment company and practiced law for 13 years. She also served as a U.S. Court of Appeals judicial clerk. Cafaro is an owner of the MLB Baltimore Orioles, the NHL Pittsburgh Penguins, and the NWSL Chicago Red Stars. She established the Cafaro Scholars program at the University of Chicago Law School, providing full scholarships to high-potential students whose parents did not attend college.

Robert F. Probst
Executive Vice President, Chief Financial Officer and Interim Chief Accounting Officer

Robert F. Probst has been Ventas's Executive Vice President and Chief Financial Officer since October 2014, and also serves as Interim Chief Accounting Officer since February 2026. Before joining Ventas, Mr. Probst was Senior Vice President and Chief Financial Officer of Beam Inc., a global spirits distributor, from its inception as a stand-alone publicly traded company in October 2011 to its sale to Suntory Holdings Limited in May 2014. He also held roles as Vice President of Finance, Strategy and M&A for the Medication Delivery business division at Baxter International, Inc., and spent eight years with UK-based Diageo PLC, where he was most recently Chief Financial Officer, Global Supply. His early career included roles at The Pillsbury Company and as a Commercial Lending Officer with The Northern Trust Bank.

J. Justin Hutchens
Executive Vice President, Senior Housing and Chief Investment Officer

J. Justin Hutchens has served as Ventas's Executive Vice President, Senior Housing since March 2020 and took on the additional role of Chief Investment Officer in January 2023. He is responsible for Ventas's Senior Housing portfolio and the company's capital allocation strategy. Prior to Ventas, Mr. Hutchens served as Chief Executive Officer for HC-One, which grew to become Britain's largest residential and nursing care home operator. He has held senior executive positions in both publicly traded and private equity-backed organizations, including President and Chief Investment Officer of HCP (now Healthpeak Properties, Inc.) (NYSE: PEAK), and Chief Executive Officer, Chief Operating Officer, and President of National Health Investors (NYSE: NHI). He was also Chief Operating Officer of Emeritus Corporation, which was acquired by Brookdale Senior Living, Inc. in 2014.

Carey S. Roberts
Executive Vice President, General Counsel, Ethics & Compliance Officer and Corporate Secretary

Carey S. Roberts joined Ventas in the first quarter of 2020 as Executive Vice President, General Counsel, and Ethics & Compliance Officer, and has served as Corporate Secretary since March 2020. She leads the company’s legal, compliance, and enterprise risk management functions. Before Ventas, Ms. Roberts was Executive Vice President, Chief Legal Officer, and Corporate Secretary of Assurant, Inc.. She also previously served as Deputy General Counsel, Global Chief Compliance Officer, and Corporate Secretary of Marsh & McLennan Companies, Inc., and was a partner in the corporate practice of Covington & Burling LLP.

Peter J. Bulgarelli
Executive Vice President, Outpatient Medical & Research and President and CEO, Lillibridge Healthcare Services, Inc.

Peter J. Bulgarelli is the Executive Vice President, Outpatient Medical & Research at Ventas, Inc., and also holds the titles of President and CEO of Lillibridge Healthcare Services, Inc.. As of November 2025, it was announced he plans to retire in May 2026.

AI Analysis | Feedback

Here are the key risks to Ventas's business:
  1. Interest Rate Fluctuations and Substantial Debt Burden: Ventas, as a Real Estate Investment Trust (REIT), relies significantly on debt to fund its extensive portfolio, particularly in senior housing. The company has a substantial debt burden, with long-term debt approximating $12.57 billion as of Q3 2025 and $13.49 billion as of December 31, 2023. A high interest rate environment poses a crucial risk as it increases borrowing costs, impacts the value of real estate assets, and can limit Ventas's ability to refinance existing debt or pursue new acquisitions.

  2. Operational Risks, Reliance on Third-Party Managers and Tenants, and Expense Pressures: Ventas's business performance is heavily dependent on the operational execution and financial health of its third-party managers and tenants. Deterioration in their condition, such as underperforming senior housing operators or challenges with occupancy rates, directly affects Ventas's revenues. The company also faces increased expense pressures, particularly from inflation and rising labor costs in property-level operating expenses, which can impact margins. Furthermore, tenant concentration risk exists, with a few major tenants contributing a significant portion of net operating income.

  3. Regulatory Risks and Changes in Healthcare Policy: Ventas operates in the highly regulated healthcare industry, making it susceptible to changes in the U.S. political and regulatory environment. Specifically, alterations in healthcare funding, reimbursement rates from programs like Medicare and Medicaid, and other stringent regulations can negatively impact the financial performance of Ventas's tenants. Such changes can directly affect their ability to pay rent and, consequently, Ventas's financial results and operations.

AI Analysis | Feedback

The accelerated shift towards virtual healthcare delivery (telemedicine) and expanding home-based care models threatening the long-term demand for physical healthcare real estate.

AI Analysis | Feedback

For Ventas (VTR), the addressable markets for its main products and services in the U.S. are as follows:

  • U.S. Senior Living Market: This market was valued at approximately $943.90 billion in 2025 and is projected to reach $1.33 trillion by 2033.
  • U.S. Medical Office Buildings (MOBs) Market: This market generated a revenue of approximately $14.08 billion in 2023 and is expected to reach $22.04 billion by 2030.
  • U.S. Healthcare Real Estate Market (Overall): This broader market, which encompasses various healthcare property types including senior living and medical office buildings, was estimated at $1.32 trillion in 2024 and is expected to reach an estimated $2.27 trillion by 2030.

Addressable market size for Life Sciences Real Estate: null

AI Analysis | Feedback

Ventas (VTR) is expected to drive future revenue growth over the next 2-3 years through several key strategies and market dynamics:

  1. Strong Performance in Senior Housing Operating Portfolio (SHOP): Ventas anticipates continued robust performance from its Senior Housing Operating Portfolio (SHOP), driven by occupancy growth and increasing same-store Net Operating Income (NOI). The company reported significant SHOP same-store NOI growth in 2025 and projects continued strong growth in 2026, with a forecasted range of 13%-17% for same-store NOI growth, fueled by expected occupancy growth of 270 basis points.
  2. Strategic Senior Housing Acquisitions and Investments: The company is actively pursuing and completing value-creating investments, particularly in high-quality senior housing properties. Ventas closed $2.5 billion in senior housing acquisitions in 2025 and has set a target of approximately $2.5 billion for new senior housing investments in 2026, aiming to enhance enterprise growth.
  3. Favorable Demographic Tailwinds: Ventas is positioned to benefit from the significant demographic trend of an aging population. The baby boomer generation beginning to turn 80 in 2026 is projected to drive a 28% surge in the over-80 population over the next five years, creating strong demand for senior housing amidst low new supply starts. This demographic shift provides a structural advantage and underpins future growth.
  4. Operational Efficiencies and Ventas Operational Insights (Ventas OI): The company leverages its proprietary Ventas Operational Insights (Ventas OI) platform and collaborates with its operators to enhance efficiency and performance across its portfolio. This execution is expected to contribute to organic growth and outperformance.
  5. Pricing Power and Revenue Per Occupied Room (RevPOR) Growth: Supported by strong demand driven by demographic trends and effective operational management, Ventas expects to maintain and expand its pricing power. This is anticipated to lead to continued growth in revenue per occupied room (RevPOR) within its senior housing portfolio.

AI Analysis | Feedback

Share Repurchases

  • Ventas has reported $0.00 in share buybacks as of February 27, 2026.

Share Issuance

  • Ventas generated over $7 billion in capital during 2025, including $3.2 billion raised through equity.
  • In the third quarter of 2025, Ventas settled 31.3 million shares under forward sales agreements, resulting in gross proceeds of $2.1 billion year-to-date.
  • Ventas's shares outstanding increased by 11.11% in 2025 to 0.463 billion from 0.416 billion in 2024.

Inbound Investments

  • Aberdeen Group plc increased its stake in Ventas by 8.3% in the third quarter, owning 1,580,923 shares valued at approximately $109.99 million.
  • Hudson Bay Capital Management LP acquired a new stake in Ventas during the second quarter, valued at around $17,568,000.
  • Institutional investors collectively own approximately 94.18% of Ventas.

Outbound Investments

  • Ventas completed $2.5 billion in senior housing investments during 2025.
  • The company plans to make approximately $2.5 billion in senior housing investments in 2026.
  • As of early 2026, Ventas has already closed over $800 million in wholly-owned senior housing deals across seven transactions.

Capital Expenditures

  • Ventas reported capital expenditures of -$580.8 million as of September 30, 2025.
  • Expected FAD (Funds Available for Distribution) capital expenditures for 2026 are approximately $400 million at the midpoint.
  • The primary focus of capital expenditures includes refreshing the portfolio with NOI (Net Operating Income) generating CapEx to enhance the competitive positioning of its communities, particularly in senior housing.

Better Bets vs. Ventas (VTR)

Trade Ideas

Select ideas related to VTR.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
SBAC_3272026_Dip_Buyer_FCFYield03272026SBACSBA CommunicationsDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
3.0%3.0%0.0%
HIW_3132026_Dip_Buyer_ValueBuy03132026HIWHighwoods PropertiesDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin
-0.2%-0.2%-4.1%
ARE_3062026_Insider_Buying_GTE_1Mil_EBITp+DE_V203062026AREAlexandria Real Estate EquitiesInsiderInsider Buys | Low D/EStrong Insider Buying
Companies with strong insider buying in the last 1 month, positive operating income and reasonable debt / market cap
-7.1%-7.1%-7.8%
VNO_3062026_Insider_Buying_GTE_1Mil_EBITp+DE_V203062026VNOVornado Realty TrustInsiderInsider Buys | Low D/EStrong Insider Buying
Companies with strong insider buying in the last 1 month, positive operating income and reasonable debt / market cap
-3.5%-3.5%-8.3%
KRC_2272026_Dip_Buyer_ValueBuy02272026KRCKilroy RealtyDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin
-3.6%-3.6%-5.4%
VTR_6302020_Dip_Buyer_ValueBuy06302020VTRVentasDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin
35.3%61.6%-6.4%

Recent Active Movers

Peer Comparisons

Peers to compare with:

Financials

VTRWELLOHIHRARENHIMedian
NameVentas WelltowerOmega He.Healthca.Alexandr.National. 
Mkt Price87.57214.2347.4218.5940.4176.6262.02
Mkt Cap41.3147.814.16.56.93.710.5
Rev LTM5,83410,6671,1901,1522,8553762,023
Op Inc LTM85835574495500191427
FCF LTM1,0022,8488791271,403237940
FCF 3Y Avg7352,1997492161,480207742
CFO LTM1,6472,8828794571,4032371,141
CFO 3Y Avg1,3652,2477494861,4802101,057

Growth & Margins

VTRWELLOHIHRARENHIMedian
NameVentas WelltowerOmega He.Healthca.Alexandr.National. 
Rev Chg LTM18.5%35.8%13.2%-7.8%-6.0%12.1%12.6%
Rev Chg 3Y Avg12.3%23.1%10.7%10.2%2.7%10.6%10.6%
Rev Chg Q21.7%41.2%14.3%-11.2%-12.1%23.4%18.0%
QoQ Delta Rev Chg LTM5.0%9.4%3.5%-2.7%-3.1%5.6%4.2%
Op Inc Chg LTM25.9%-69.0%12.8%159.4%-29.7%1.3%7.0%
Op Inc Chg 3Y Avg25.2%-7.0%24.1%30.8%-5.6%13.8%18.9%
Op Mgn LTM14.7%3.3%62.5%8.2%17.5%50.8%16.1%
Op Mgn 3Y Avg12.6%10.8%58.9%5.1%21.9%54.3%17.3%
QoQ Delta Op Mgn LTM-0.0%-12.9%0.1%3.1%-1.3%-2.1%-0.7%
CFO/Rev LTM28.2%27.0%73.8%39.7%49.1%63.0%44.4%
CFO/Rev 3Y Avg26.7%26.8%70.0%39.2%50.5%60.9%44.9%
FCF/Rev LTM17.2%26.7%73.8%11.0%49.1%63.0%37.9%
FCF/Rev 3Y Avg14.2%26.2%70.0%17.2%50.5%60.1%38.4%

Valuation

VTRWELLOHIHRARENHIMedian
NameVentas WelltowerOmega He.Healthca.Alexandr.National. 
Mkt Cap41.3147.814.16.56.93.710.5
P/S7.113.911.85.62.49.78.4
P/Op Inc48.2416.118.968.513.819.133.6
P/EBIT48.0859.616.7-154.6-11.218.817.7
P/E164.3157.723.8-26.4-6.525.724.7
P/CFO25.151.316.014.24.915.415.7
Total Yield2.7%0.6%9.8%2.2%-3.7%8.5%2.4%
Dividend Yield2.1%0.0%5.6%5.9%11.7%4.6%5.1%
FCF Yield 3Y Avg2.7%2.7%7.4%3.5%11.3%6.8%5.2%
D/E0.30.10.30.61.90.30.3
Net D/E0.30.10.30.61.80.30.3

Returns

VTRWELLOHIHRARENHIMedian
NameVentas WelltowerOmega He.Healthca.Alexandr.National. 
1M Rtn7.6%9.4%6.5%10.3%-12.2%-6.8%7.0%
3M Rtn16.0%17.2%11.5%12.5%-29.4%-2.2%12.0%
6M Rtn26.6%20.1%22.3%6.5%-33.8%4.4%13.3%
12M Rtn31.4%46.1%33.3%26.5%-44.0%7.0%28.9%
3Y Rtn100.8%189.0%117.4%16.2%-61.9%81.2%91.0%
1M Excs Rtn-4.5%-2.7%-5.6%-1.8%-24.3%-18.9%-5.1%
3M Excs Rtn13.7%14.9%9.2%10.2%-31.7%-4.5%9.7%
6M Excs Rtn20.9%16.2%15.7%-2.8%-51.3%-0.8%7.4%
12M Excs Rtn2.8%19.0%5.0%-2.7%-72.4%-22.3%0.0%
3Y Excs Rtn40.9%130.0%48.3%-54.7%-134.7%7.7%24.3%

Financials

Segment Financials

Assets by Segment
$ Mil20252024202320222021
Senior Housing Operating Portfolio (SHOP)12,86412,36912,81210,65310,142
Outpatient Medical and Research Portfolio (OM&R)6,9436,5586,3426,7107,173
Triple-net leased properties (NNN)4,1214,2724,5795,1486,382
Non-Segment797958   
All other assets  9861,419995
Total24,72524,15824,71823,92924,692


Price Behavior

Price Behavior
Market Price$87.57 
Market Cap ($ Bil)41.3 
First Trading Date05/05/1997 
Distance from 52W High0.0% 
   50 Days200 Days
DMA Price$84.46$75.25
DMA Trendupup
Distance from DMA3.7%16.4%
 3M1YR
Volatility21.2%19.2%
Downside Capture-0.07-0.14
Upside Capture51.9314.01
Correlation (SPY)21.7%-0.3%
VTR Betas & Captures as of 3/31/2026

 1M2M3M6M1Y3Y
Beta0.610.490.300.000.230.38
Up Beta0.111.140.760.300.290.34
Down Beta0.270.510.48-0.000.350.27
Up Capture87%77%27%18%13%27%
Bmk +ve Days7162765139424
Stock +ve Days10232865131400
Down Capture77%5%0%-37%-5%61%
Bmk -ve Days12233358110323
Stock -ve Days12193459115341

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with VTR
VTR32.2%19.1%1.33-
Sector ETF (XLRE)12.2%13.6%0.6045.6%
Equity (SPY)31.5%12.5%1.92-0.7%
Gold (GLD)38.6%27.2%1.1811.5%
Commodities (DBC)45.9%18.0%1.95-9.8%
Real Estate (VNQ)14.4%13.4%0.7543.6%
Bitcoin (BTCUSD)-19.0%42.1%-0.39-7.2%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with VTR
VTR13.2%24.9%0.48-
Sector ETF (XLRE)4.2%19.1%0.1367.9%
Equity (SPY)12.9%17.1%0.5939.2%
Gold (GLD)20.2%17.8%0.9215.6%
Commodities (DBC)14.8%19.1%0.6311.0%
Real Estate (VNQ)3.4%18.8%0.0968.7%
Bitcoin (BTCUSD)7.3%56.2%0.3510.1%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with VTR
VTR7.7%34.7%0.31-
Sector ETF (XLRE)6.8%20.4%0.2968.8%
Equity (SPY)14.9%17.9%0.7145.5%
Gold (GLD)13.4%15.9%0.7011.0%
Commodities (DBC)9.9%17.7%0.4619.6%
Real Estate (VNQ)5.4%20.7%0.2372.9%
Bitcoin (BTCUSD)67.8%66.9%1.0713.6%

Smart multi-asset allocation framework can stack odds in your favor. Learn How

Short Interest

Short Interest: As Of Date4152026
Short Interest: Shares Quantity19.0 Mil
Short Interest: % Change Since 33120264.4%
Average Daily Volume3.1 Mil
Days-to-Cover Short Interest6.2 days
Basic Shares Quantity471.6 Mil
Short % of Basic Shares4.0%

Earnings Returns History

Expand for More
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
4/27/20263.4%  
2/5/20263.4%6.7%8.0%
10/29/20256.6%7.5%15.2%
7/30/20251.1%3.0%1.6%
4/30/2025-6.5%-5.7%-8.3%
2/12/20258.3%11.5%11.6%
8/1/20242.0%6.7%12.3%
5/1/20245.5%8.3%14.7%
...
SUMMARY STATS   
# Positive161414
# Negative899
Median Positive2.5%6.7%12.0%
Median Negative-3.3%-4.3%-6.9%
Max Positive11.2%16.1%68.7%
Max Negative-6.8%-9.7%-11.1%

SEC Filings

Expand for More
Report DateFiling DateFiling
12/31/202502/06/202610-K
09/30/202510/30/202510-Q
06/30/202507/31/202510-Q
03/31/202505/01/202510-Q
12/31/202402/13/202510-K
09/30/202410/31/202410-Q
06/30/202408/02/202410-Q
03/31/202405/02/202410-Q
12/31/202302/15/202410-K
09/30/202311/03/202310-Q
06/30/202308/04/202310-Q
03/31/202305/09/202310-Q
12/31/202202/10/202310-K
09/30/202211/04/202210-Q
06/30/202208/05/202210-Q
03/31/202205/06/202210-Q

Recent Forward Guidance [BETA]

Latest: Q1 2026 Earnings Reported 4/27/2026

Forward GuidanceGuidance Change
MetricLowMidHigh% Chg% DeltaChangePrior
2026 Attributable Net Income Per Share0.560.590.634.4% RaisedGuidance: 0.57 for 2026
2026 Nareit FFO Per Share3.693.733.761.2% RaisedGuidance: 3.68 for 2026
2026 Normalized FFO Per Share3.823.853.890.7% RaisedGuidance: 3.83 for 2026
2026 Senior Housing Investment Volume 3.00 Bil 20.0% RaisedGuidance: 2.50 Bil for 2026

Prior: Q4 2025 Earnings Reported 2/5/2026

Forward GuidanceGuidance Change
MetricLowMidHigh% Chg% DeltaChangePrior
2026 Attributable Net Income Per Share0.520.570.6212.9% RaisedGuidance: 0.51 for 2025
2026 Nareit FFO Per Share3.633.683.736.8% RaisedGuidance: 3.44 for 2025
2026 Normalized FFO Per Share3.783.833.8810.5% RaisedGuidance: 3.46 for 2025
2026 Senior Housing Investments 2.50 Bil 0 AffirmedGuidance: 2.50 Bil for 2025
2026 Disposition Proceeds 300.00 Mil    
2026 Interest Expense 636.00 Mil    
2026 FAD Capital Expenditures 400.00 Mil    

Insider Activity

Expand for More
#OwnerTitleHoldingActionFiling DatePriceSharesTransacted
Value
Value of
Held Shares
Form
1Roberts, Carey SEVP and GCDirectSell213202685.0035,5323,020,1176,183,964Form
2Cafaro, Debra AChairman and CEODirectSell210202682.2310,322848,75191,604,119Form
3Cafaro, Debra AChairman and CEODirectSell203202677.6610,322801,60586,515,769Form
4Cafaro, Debra AChairman and CEODirectSell106202677.2610,322797,47588,516,052Form
5Probst, Robert FEVP and CFODirectSell106202677.2529,9302,312,18810,694,469Form